All In Biotech

Drug Trial Radar · NCT02130063

IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose

A Phase III, Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose in Subjects With Iron Deficiency Anaemia and Who Are Intolerant or Unresponsive to Oral Iron Therapy or Who Need Iron Rapidly (PROVIDE)

Last checked: Nov 20, 2026Latest source record: Sep 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 511 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

511

Actual

Start

May 2014

Primary completion

Aug 2015

Study completion Aug 2015

Sponsor

Lead sponsor
Pharmacosmos A/SIndustry
Sponsor type
Industry
Collaborators
BioStata; ClinStar, LLC; Laboratory Corporation of America
First posted
May 2, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the trial is to evaluate and compare the effect of iron isomaltoside 1000 to iron sucrose in its ability to increase haemoglobin (Hb) in subjects with IDA when oral iron preparations are ineffective or cannot be used or where there is a clinical need to deliver iron rapidly.

Conditions

  • Iron Deficiency Anaemia

Interventions

  • iron isomaltoside 1000 (Monofer®)Drug

  • iron sucrose (Venofer®)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Subjects With an Haemoglobin (Hb) Increase of ≥ 2 g/dL From Baseline at Any Time From Week 1 to Week 5Time frame: From baseline to week 5

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Wilmington, Delaware

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.